Vol.
66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations
(i)
Unsupervised or take-home use.
To limit
the potential for diversion of opioid agonist treatment medications to the
illicit market, opioid agonist treatment medications dispensed to patients for
unsupervised use shall be subject to the following requirements.
(1)
Any patient in comprehensive maintenance
treatment may receive a single take-home dose for a day that the clinic is
closed for business, including Sundays and State and Federal holidays.
(2)
Treatment program decisions on dispensing opioid
treatment medications to patients for unsupervised use beyond that set forth in
paragraph (i)(1) of this section, shall be determined by the medical director.
(i)
During the first 90 days of treatment, the
take-home Supply (beyond that of paragraph (i)(1) of this section) is limited to
a single dose each week and the patient shall ingest all other doses under
appropriate supervision as provided for under the regulations in this subpart.
(ii)
In the second 90 days of treatment, the
take-home Supply (beyond that of paragraph (i)(1) of this section) is two doses
per week.
(iii)
In the third 90 days of treatment, the take-home
supply (beyond that of paragraph (i)(1) of this section) is three doses per
week.
(iv)
In the remaining months of the first year, a
patient may be given a maximum 6-day supply of take-home medication.
(v)
After 1 year of continuous treatment, a patient
may be given a maximum 2-week supply of take-home medication.
(vi)
After 2 years of continuous treatment, a patient
may be given a maximum one-month supply of take-home medication, but must make
monthly visits.
(4) No
medications shall be dispensed to patients in short-term detoxification
treatment or interim maintenance treatment for unsupervised or take-home use.